Cancer/testis Antigen 1B (CTAG1B) Antikörper

Details zu Produkt Nr. ABIN4265165, Anbieter: Anmelden zum Anzeigen
Antigen
  • CTAG
  • ESO1
  • CT6.1
  • CTAG1
  • LAGE-2
  • LAGE2B
  • NY-ESO-1
  • cancer/testis antigen 1B
  • CTAG1B
Reaktivität
Human
114
1
Wirt
Ziege
59
42
13
Klonalität
Polyklonal
Konjugat
Unkonjugiert
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
Applikation
ELISA, Microarray (MA)
80
50
26
24
21
14
2
1
1
1
1
Optionen
Hersteller
Anmelden zum Anzeigen
Hersteller Produkt- Nr.
Anmelden zum Anzeigen
Immunogen Peptide with sequence C-AELARRSLAQDAP corresponding to internal region according to NP_001318.1.
Reinigung Immunogen affinity purified
Andere Bezeichnung CTAG1B (CTAG1B Antibody Abstract)
Hintergrund Gene Symbol: CTAG1B
Gen-ID 1485
NCBI Accession NP_001318
Applikationshinweise Peptide ELISA Detection limit 1:16000, MicroarrayMA successful usage is reported in scientific literature (PMID: 22922091). WB: Preliminary experiments gave an approx. 28 kDa band in human testis lysates after 0.3 μg/mL antibody staining. Please note that currently we cannot find an explanation in the literature for the band we observe given the calculated size of 18.0 kDa band according to NP_001318.1. The 28 kDa band was successfully blocked by incubation with the immunizing peptide.
Kommentare

The antibodies are intended for use in vitro experiments only. Our antibodies have not been tested nor are recommended for use in vivo.

Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Konzentration 0.5 mg/mL
Buffer 0.5 mg/mL Tris ( pH 7.3) and 0.5 % BSA
Buffer contains: 0.02 % Sodium Azide
Konservierungsmittel Sodium azide
Vorsichtsmaßnahmen This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung -20 °C
Informationen zur Lagerung Store at -20°C. Avoid freeze-thaw cycles.
Produkt verwendet in: Adams, ONeill, Nonaka, Hardin, Chiriboga, Siu, Cruz, Angiulli, Angiulli, Ritter, Holman, Shapiro, Berman, Berner, Shao, Manches, Pan, Venhaus, Hoffman, Jungbluth, Gnjatic, Old, Pavlick, Bhardwaj: "Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 181, Issue 1, pp. 776-84, 2008 (PubMed).

Haben Sie etwas anderes gesucht?